1. Long term follow-up after administration of human gene therapy products Publication: Silver Spring, MD : Center for Biologics Evaluation and Research, January 2020 Subject(s): Genetic Therapy -- adverse effectsProduct Surveillance, PostmarketingDrug Evaluation, PreclinicalUnited StatesUnited States. Department of Health and Human Services.United States. Food and Drug Administration.
